HCPCS Code J2840

Injection, sebelipase alfa, 1 mg
Code effective Jan 01, 2017

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J2840 is a valid 2026 HCPCS code meaning Injection, sebelipase alfa, 1 mg or (Inj sebelipase alfa 1 mg) for short. HCPCS J2840 has been effective since 01/01/2017 and applies to Medical care.


HCPCS Code Details - J2840

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J2840
Description

Long description:
Injection, sebelipase alfa, 1 mg

Short description:
Inj sebelipase alfa 1 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
ASC payment group code Effective Jan 01, 2017 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2017
Date added Added Jan 01, 2017

See also

  • HCPCS J2820 · Injection, sargramostim (gm-csf), 50 mcg

  • HCPCS C9478 · Injection, sebelipase alfa, 1 mg

  • HCPCS J2850 · Injection, secretin, synthetic, human, 1 microgram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.